Talea Group S.p.a. · MIL:TALEA

Talea — Farmaè — Non-Deal Roadshow (October 2021)

28 slides from Talea's roadshow presentation, Oct 20, 2021

  1. Slide 1: Alantra Virtual Roadshow

    Alantra Virtual Roadshow 20/21 October 2021

  2. Slide 2: Farmaè SpA: the undisputed online leader in healthcare, beauty and wellness

    FARMAE’ SPA: THE UNDISPUTED ON-LINE LEADER IN THE HEALTHCARE, BEAUTY AND WELLNESS SECTOR* €58.7m → +25% Continuos growth of revenues and all KPIs in 9M2021 vs an exceptional 2020 driven by Covid-19 pandemia Revenues 9M2021 YoY Growth First Italian online e- 10 Retailer in pharma & ~45k Physical stor

  3. Slide 3: Update on 9M2021 KPIs

    UPDATE ON 9M2021 KPIs Site Visits (m) Product sold (m) CAGR 40.5 -5% CAGR 7.5 +10% 2016-2020 2016-2020 5.4 5.9 +65% 30.4 28.9 +81% 22.8 4.2 2.7 13.0 8.1 1.4 5.5 0.7 2016 2017 2018 2019 2020 9M20 9M21 2016 2017 2018 2019 2020 9M20 9M21 Orders (m) Conversion Rate (%) CAGR 2016-2020 +16% +20% +26% CAGR

  4. Slide 4: A unique history of growth

    A UNIQUE HISTORY OF GROWTH 2021 AmicaFarmacia acquisition 2020 Sanort & Valnan FY2020 acquisition 2019 €65.5m Beautyè Launch 2019 2019 €37.5m Listed on the AIM Market 2019 New Logistic Hub €24.9m 2017 2015 €13.3m 2018 Opening of First co-marketing offline stores in €7.6m initiatives Tuscany €3.4m 20

  5. Slide 5: Dedicated platforms to address different markets

    DEDICATED PLATFORMS TO ADDRESS DIFFERENT MARKETS www.farmaegroup.it www.farmae.it www.beautye.it www.sanort.com www.valnan.it 9 1 Stores in Italy Store in Tuscany Heavy orthopedic platform Online marketing agency & & for disabled, and specialized in Digital platform Digital platform healthcare items

  6. Slide 6: A scalable and omnichannel business model based on three pillars

    A SCALABLE AND OMNICHANNEL BUSINESS MODEL BASED ON THREE PILLARS 01 02 03 Commercial Tech Media OnLife E-retail Tech Company Media Company Integration of online, offline, logistics Constant introduction of innovations The careful management and and data in a single value chain at both company and we

  7. Slide 7: The reference point for customers and the industry

    THE REFERENCE POINT FOR CUSTOMERS AND THE INDUSTRY Customer Care Technology Logistics Customer Industry Omnichannel Products Offer Data Economy Focus on Customers Focus on Industry Unique customer experience thanks to the state-of-the- Unique media platform at the service of the main art and scalabl

  8. Slide 8: The best technology to provide the best customer experience

    THE BEST TECHNOLOGY TO PROVIDE THE BEST CUSTOMER EXPERIENCE Artificial Intelligence and Chatbots integrated with Facebook and Salesforce State-of-the-art personalized, user-friendly platform (both for mobile and desktop users) enabling data matching between online and offline Google Accelerated Mobi

  9. Slide 9: Pharma and beauty industries and partners

    PHARMA AND BEAUTY INDUSTRIES AND PARTNERS COMPETITIVE SCENARIO PARTNERS 9 * Source: IQVIA

  10. Slide 10: A unique unparalleled offering

    A UNIQUE UNPARALLELED OFFERING • ~ 45k SKUs* • 33% average discount vs offline Cosmetics 29% • High value products with long shelf life Food Supplements 34% • Small weight and size • Low return rates • Extended customer lifetime 16% OTC Pet care 1% Orthopedics and electronic 5% medical devices Omeop

  11. Slide 11: Advanced logistic hubs to efficiently serve customers

    ADVANCED LOGISTIC HUBS TO EFFICIENTLY SERVE CUSTOMERS Farmaè 5,000 sqm new warehouse to support growth Automated logistics hub located in Migliarino Pisano (PI) 48 h ▪ equipped with a state-of-the-art estimated maximum time for a delivery fully automated system € 19.90 ▪ achieves significant efficie

  12. Slide 12: A clear strategy to consolidate market leadership

    A CLEAR STRATEGY TO CONSOLIDATE MARKET LEADERSHIP Omni-channel: integration of physical and online channels into a single value chain Multicategory: enlarging the product offer with the introduction of new categories to address attractive and complementary markets Media Platform: Enhancing the comme

  13. Slide 13: Focus on AmicaFarmacia

    Aca 7 pion —sF aia y| FOCUS ON AMICAFARMACIA Meritene PROVA MERITENE® PROACTIVE: .. L'ALLEATO DELLE DONNE PER uv +FARMAEGROUP

  14. Slide 14: Strong growth potential of the Italian e-commerce market

    STRONG GROWTH POTENTIAL OF THE ITALIAN E-COMMERCE MARKET 2021E € 38.6 bn (+19%) E-commerce Market Value E-commerce € 30.6 bn (+18%) Products Market € 8.0 bn (+22%) Services 9.0% Penetration rate 2020 € 10.8 bn Personal Care & OTC Market Value Personal Care & Otc Market * € 389 m (+23%) Personal Care

  15. Slide 15: Today we are ready to become the undisputed Italian online pharma champion

    TODAY WE ARE READY TO BECOME THE UNDISPUTED ITALIAN ONLINE PHARMA CHAMPION 2020 Revenues (€ m) 93.3 27.8 65.5 19.3(1) 19.3 Please note that comps revenues are reported only for illustrative purposes. Source: IQVIA, Aida 15 1) Gross revenues. Source: Assemblea Delibera Aucap

  16. Slide 16: AmicaFarmacia 2020 key figures

    AMICAFARMACIA 2020 KEY FIGURES €27.8m → +34% → +29% Revenues 2018-2020 Revenues 2020 YoY Growth CAGR 1.8 Days 1 Pharmacy ~40k Average order fulfilment time 1 Para - Pharmacy SKUs €51(1) ca. 1.6%(1) 26.9m(1) Average ticket in 2020 Average conversion Sessions on the (net of VAT) rate in 2020 website i

  17. Slide 17: Important synergies to consolidate market leadership

    IMPORTANT SYNERGIES TO CONSOLIDATE MARKET LEADERSHIP AND ACCELERATE THE DEVELOPMENT OF THE BUSINESS MODEL Improved commercial purchasing Strengthen product portfolio in the 1 Health and Wellness sector 5 conditions thanks to a greater critical mass Consolidation of its positioning in Further develop

  18. Slide 18: 100 days achievements since the acquisition announcement

    100 DAYS ACHIEVEMENTS SINCE THE ACQUISITION ANNOUNCEMENT Italian leading online group: distribution of over-the-counter medicines and health and wellness products Larger pool of customers: user base of almost 60 million people Great technological potential: personalised offers and unique sales oppor

  19. Slide 19: New governance

    NEW GOVERNANCE BOARD OF DIRECTORS BOARD OF STATUTORY AUDITORS Riccardo Iacometti Sergio Marchese Chairman & CEO Chairman Alberto Maglione Marco Di Filippo Giuseppe Cannarozzi Alberto Colella Monica Barbara Baldini Vice President Director Director Regular Statutory Auditor Regular Statutory Auditor G

  20. Slide 20: Financials

    Financials +FARMAEGROUP

  21. Slide 21: H1 2021 main financial figures

    H1 2021 MAIN FINANCIAL FIGURES Revenues (€/m) EBITDA (€/m) CAGR CAGR 2016-2020 2016-2020 +71% 65.5 +78% 58.7 1.8 +55% YoY 37.5 40.0 1.3 1.0 24.8 0.8 0.6 13.3 0.4 7.6 0.1 2016 2017 2018 2019 2020 1H2021 9M2021 2016 2017 2018 2019 2020 1H2020 1H2021 EBIT (€/m) Net Profit (€/m) CAGR 2016-2020 +124% 1.0

  22. Slide 22: H1 results: combining growth with profitability

    H1 RESULTS: COMBINING GROWTH WITH PROFITABILITY €/000 1H2021 1H2020 YoY % Total Revenues grew by 28% YoY Sales Revenues 40,007 31,310 28% driven by rising active customers (0.4m), Other Revenues 68 349 (81%) orders (0.8m), and AOV (€43.9). Conversion rate expanded from 3.3% to Total Revenues 40,075

  23. Slide 23: Business units analysis

    BUSINESS UNITS ANALYSIS Business Units analysis confirms the strong growth in all business segments +25% YoY Online Sales growth, thanks to the increase in the €/m 1H2021 1H2020 YoY % number and loyalty of active customers, to the expansion of the range of products offered and to the growth in the c

  24. Slide 24: Financial highlights

    FINANCIAL HIGHLIGHTS €/000 1H2021 2020 Fixed Assets 9,993 9,882 Net Working Capital (1,873) (783) Net Financial Position 4,290 3,355 Net Equity 11,644 11,774 €/m 1.9 4.2 1.5 0.4 14.6 10.6 14 9.8 0.1 10.8 6.8 0.6 4.2 2.3 3.7 1.6 0.1 (2.6) (4.8) (0.5) (0.4) (7.9) (6.4) (11.8) (19.7) (13.9) (14.1) (21.

  25. Slide 25: NFP bridge

    NFP BRIDGE €/m 2.4 4.3 3.4 (0.2) (0.6) (0.7) NFP Material Immaterial Interest Cashflow NFP 2020 Fixed Assets Fixed Assets Paid generated 1H2021 Net cash improved from €3.4m to €4.3m after €0.8m of capex and thanks to efficient WC management Inventory was down vs FY2020 and slightly higher in 1H20 (+

  26. Slide 26: Contacts

    CONTACTS Farmaè S.p.A. Media Relations IR Manager Via Aurelia Nord 141 – 55049 Daniele Pinosa – SEC S.p.A. Alberto Maglione Viareggio (LU) pinosa@secrp.com ir@farmaegroup.it www.farmaegroup.it Ph. +39 0584 1660552 M. +39 335 7233872 IR Advisor Fabio Santilio – SEC S.p.A. Vincenza Colucci – CDR Commu

  27. Slide 27: Disclaimer

    DISCLAIMER “This Presentation contains certain forward-looking statements. Forward-looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words "believes," "expects," "predicts," "intends," "projects," "plans," "est

  28. Slide 28: Thank you

    THANK YOU +FARMAEGROUP

Farmaè — Non-Deal Roadshow (October 2021) on 6ix